NCT01206933
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +26 more
- Locations
-
- George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
Clinical trial condition
HIV Infections
Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.
1,675 public trials
170 recruiting studies
HIV Infections trial results
NCT02670772
- Conditions
- Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
- Locations
-
- VHS-YRG Care Medical Centre Chennai, Tamil Nadu, India
- Charlotte Maxeke Johannesburg Academic Hospital Johannesburg, Gauteng, South Africa
- The Infectious Disease Institute (IDI), Mulago Hospital Complex Kampala, Uganda
NCT02264509
- Conditions
- Acquired Immunodeficiency Syndrome, Arterial Insufficiency, Arterial Occlusive Diseases, +20 more
- Locations
-
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, D.f., Mexico, Mexico
Completed
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
NCT02376582
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI) Entebbe, Uganda
- Medical Research Council (MRC) /Uganda Virus Research Institute (UVRI) Masaka, Uganda
NCT01994603
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Alcohol Related Neurodevelopmental Disorder, +26 more
- Locations
-
- University of Oklahoma Oklahoma City, Oklahoma, United States
- St. Petersburg State University Saint Peterburg, Russia
NCT00202241
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +25 more
- Locations
-
- Queen's University Kingston, Ontario, Canada
NCT01328041
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
Completed
Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
NCT02411435
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT02646605
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Behavior, +18 more
- Locations
-
- Lighthouse Clinic Lilongwe, Malawi
NCT02027480
- Conditions
- AIDS (Acquired Immune Deficiency Syndrome), Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +26 more
- Locations
-
- Ahero Sub District Hospital Ahero, Nyanza, Kenya
- Ambira Sub District Hospital Ambira, Nyanza, Kenya
- Awasi Mission Awasi, Nyanza, Kenya
- Bondo District Hospital Bondo, Nyanza, Kenya